1887

Abstract

Tonsillar squamous cell carcinomas (a total of 14) were examined both for the presence of human papillomavirus (HPV) DNA and for p53 alterations. General primer- mediated HPV polymerase chain reaction (GP-PCR) revealed the presence of HPV DNA in 12/14 cases. Subsequent typing by HPV type-specific PCR and sequence or hybridization analysis of GP-PCR products revealed DNA from HPV 16 in seven cases, from HPV 33 in two cases, and from HPV 7, HPV 16/33 and HPV 33/59 each in a single case. p53 immunohistochemistry performed on nine HPV containing tonsillar carcinomas using polyclonal serum CM-1 showed elevated p53 levels in four cases. These included 3/5 HPV 16 containing carcinomas and the HPV 33/59 containing carcinoma. Analysis of p53 mutations using denaturing gradient gel electrophoresis (DGGE) of GC-clamped PCR products of exons 5 to 8 showed p53 gene alterations in 3/13 cases, incuding 2/11 HPV positive cases and 1/2 HPV negative cases. The alterations included a silent point mutation within exon 8 of an HPV 16 containing carcinoma, a 1 bp deletion within exon 8 of an HPV 33 containing carcinoma, and a missense mutation within exon 7 of one of the HPV negative carcinomas. There was evident discrepancy between p53 immunohistochemistry and gene analysis. Four HPV containing cases showing elevated p53 levels did not reveal the presence of exon 5 to 8 alterations affecting the amino acid code, suggesting the presence of mutations occurring in other exons or non-mutational p53 stabilization. The data indicate that HPV and elevated p53 can coexist in tonsillar carcinomas and that despite the low frequency of p53 mutations the presence of HPV is not exclusively related to the absence of mutated p53.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-10-2769
1994-10-01
2023-02-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/10/JV0750102769.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-10-2769&mimeType=html&fmt=ahah

References

  1. Anwar K., Nakakuki K., Imai H., Naiki H., Inuzuka M. 1993; Over-expression of p53 protein in human laryngeal carcinoma. International Journal of Cancer 53:952–956
    [Google Scholar]
  2. Beck J. S., Kwitek A. E., Cogen P. H., Metzger A. K., Duyk G. M., Sheffield V. C. 1993; A denaturing gradient gel electrophoresis assay for sensitive detection of p53 mutations. Human Genetics 91:25–30
    [Google Scholar]
  3. Bercovich J. A., Centeno C. R., Aguilar O. G., Grinstein S., Kahn T. 1991; Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. Journal of General Virology 72:2569–2572
    [Google Scholar]
  4. Brachman D. G., Graves D., Vokes E., Beckett M., Haraf D., Montag A., Dunphy E., Mick R., Yandell D., Weichselbaum R. R. 1992; Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Research 52:4832–4836
    [Google Scholar]
  5. Brambilla E., Gazzeri S., Moro D., Caron de Fromentel C., Gouyer V., Jacrot M., Brambilla C. 1993; Immunohistochemical study of p53 in human lung carcinomas. American Journal of Pathology 143:199–210
    [Google Scholar]
  6. Byrne J. C., Tsao M.-S., Fraser R. S., Howley P. M. 1987; Human papillomavirus 11 DNA in a patient with chronic laryngo-tracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. New England Journal of Medicine 317:873–878
    [Google Scholar]
  7. Caron de Fromentel C., Soussi T. 1992; p53 tumor suppressor gene: a model for investigating human mutagenesis. Genes, Chromosomes and Cancer 4:1–15
    [Google Scholar]
  8. Chang Y.-S., Lin Y.-J., Tsai C.-N., Shu C.-H., Tsai M.-S., Choo K.-B., Liu S.-T. 1992; Detection of mutations in the p53 gene in head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Letters 67:167–174
    [Google Scholar]
  9. Chiba I., Takahashi T., Nau M. M., D’Amico D., Curiel D. T., Mitsudomi T., Buchhagen D. L., Carbone D., Piantadosi S., Koga H., Reissman P. T., Slamon D. J., Holmes E. C., Minna J. D. 1990; Mutations in the p53 gene are frequent in primary, resected non small cell lung cancer. Oncogene 5:1603–1610
    [Google Scholar]
  10. Choo K.-B., Chong K. Y. 1993; Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinoma. Virology 193:1042–1046
    [Google Scholar]
  11. Cromme F. V., Meijer C. J. L. M., Snijders P. J. F., Uyterlinde A., Kenemans P., Helmerhorst TH., Stern P. L., van den Brule A. J. C., Walboomers J. M. M. 1993; Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. British Journal of Cancer 68:1372–1380
    [Google Scholar]
  12. Crook T., Wrede D., Vousden K. 1991; p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873–875
    [Google Scholar]
  13. Crook T., Wrede D., Tidy J. A., Mason W. P., Evans D. J., Vousden K. H. 1992; Clonal p53 mutation in primary cervical cancer: association with human papillomavirus negative tumours. Lancet 339:1070–1073
    [Google Scholar]
  14. Demers G. W., Halbert C. L., Galloway D. A. 1994; Elevated wild-type p53 protein in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198:169–174
    [Google Scholar]
  15. de Villiers E. M., Weidauer H., Otto H., zur Hausen H. 1985; Papillomavirus DNA in human tongue carcinomas. International Journal of Cancer 36:575–578
    [Google Scholar]
  16. Dyson N., Howley P. M., Münger K., Harlow E. 1989; The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937
    [Google Scholar]
  17. Field J. K., Spandidos D. A., Malliri A., Gosney J. R., Yiagnisis M., Stell P. M. 1991; Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. British Journal of Cancer 64:573–577
    [Google Scholar]
  18. Fujita M., Inoue M., Tanizawa O., Iwamoto S., Enomoto T. 1992; Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Research 52:5323–5328
    [Google Scholar]
  19. Greenspan D., de Villiers E. M., Greenspan J. S., de Souza Y. G., zur Hausen H. 1988; Unusual HPV types in oral warts in association with HIV infection. Journal of Oral Pathology 17:482–487
    [Google Scholar]
  20. Helland A., Holm R., Kristensen G., Kaern J., Karlsen F., Trope C., Nesland J. M., Borresen A.-L. 1993; Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. Journal of Pathology 171:105–114
    [Google Scholar]
  21. Hubbert N. L., Sedman S. A., Schiller J. T. 1992; Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. Journal of Virology 66:6237–6241
    [Google Scholar]
  22. Iggo R., Gatter K., Barter J., Lane D., Harris A. L. 1990; Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675–679
    [Google Scholar]
  23. Kessis T. D., Slebos R. J., Han S. M., Shah K., Bosch X. F., Munoz N., Hedrick L., Cho K. R. 1993; p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. American Journal of Pathology 143:1398–1405
    [Google Scholar]
  24. Lechner M. S., Mack D. H., Finicle A. B., Crook T., Vousden K. H., Laimins L. A. 1992; Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO Journal 11:3045–3052
    [Google Scholar]
  25. Lindeberg H., Syrjänen S., Kärjä J., Syrjänen K. 1989; Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. Acta Otolaryngology 107:141–149
    [Google Scholar]
  26. Maestro R., Dolcetti R., Gasparotto D., Doglioni C., Pelucchi S., Barzan L., Grandi E., Boiocchi M. 1992; High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 7:1159–1166
    [Google Scholar]
  27. Marchetti A., Buttitta F., Merlo G., Diella F., Pellegrini S., Pepe S., Macchiarini P., Chella A., Angeletti C. A., Callahan R., Bistocchi M., Squartini F. 1993; p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Research 53:2846–2851
    [Google Scholar]
  28. Medcalf E. A., Milner J. 1993; Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620 + p53 conformation. Oncogene 8:2847–2851
    [Google Scholar]
  29. Midgley R., Fisher C. J., Barter J., Vojtesek B., Lane D., Barnes D. M. 1992; Analysis of p53 expression in human tumours : an antibody raised against human p53 expressed in Escherichia coli . Journal of Cell Sciences 101:183–189
    [Google Scholar]
  30. Miller C. W., Simon K., Aslo A., Kok K., Yokota J., Buys C. H. C. M., Terada M., Koeefler H. P. 1992; p53 mutations in human lung tumors. Cancer Research 52:1695–1698
    [Google Scholar]
  31. Münger K., Werness B. A., Dyson N., Phelps W. C., Howley P. M. 1989; Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO Journal 8:4099–4105
    [Google Scholar]
  32. Niedobitek G., Pitteroff S., Herbst H., Sheperd P., Finn T., Anagnostopoulos I., Stein H. 1990; Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. Journal of Clinical Pathology 43:918–921
    [Google Scholar]
  33. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hotstetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P., Glover T., Collins F. S., Weston A., Modali R., Harris C. C., Vogelstein B. 1989; Mutations in the p53 gene occur in diverse tumor types. Nature; London: 342705–708
    [Google Scholar]
  34. Ogden G. R., Kiddie R. A., Lunny D. P., Lane D. P. 1992; Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. Journal of Oral Pathology 166:389–394
    [Google Scholar]
  35. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. 1990; The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
    [Google Scholar]
  36. Scheffner M., Münger K., Byrne J. C., Howley P. M. 1991; The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proceedings of the National Academy of Sciences, U.S.A 88:5523–5527
    [Google Scholar]
  37. Scheffner M., Takahashi T., Huibregtse J. M., Minna J. D., Howley P. M. 1992; Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. Journal of Virology 66:5100–5105
    [Google Scholar]
  38. Snijders P. J. F., van den Brule A. J. C., Schrijnemakers H. F. J., Snow G., Meijer C. J. L. M., Walboomers J. M. M. 1990; The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. Journal of General Virology 71:173–181
    [Google Scholar]
  39. Snijders P. J. F., Crome F. V., van den Brule A. J. C., Schrijnemakers H. F. J., Snow G., Meijer C. J. L. M., Walboomers J. M. M. 1992a; Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. International Journal of Cancer 51:845–850
    [Google Scholar]
  40. Snijders P. J. F., van den Brule A. J. C., Schrijnemakers H. F. J., Raaphorst P. M. C., Meijer C. J. L. M., Walboomers J. M. M. 1992b; Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly (A) sites. Journal of Virology 66:3172–3178
    [Google Scholar]
  41. Snijders P. J. F., Meijer C. J. L. M., van den Brule A. J. C., Schrijnemakers H. F. J., Snow G. B., Walboomers J. M. M. 1992c; Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. Journal of General Virology 73:2059–2066
    [Google Scholar]
  42. Snijders P. J. F., van den Brule A. J. C., Meijer C. J. L. M., Walboomers J. M. M. 1994; Papillomaviruses and cancer of the upper digestive and respiratory tracts. Current Topics in Microbiology and Immunology 186:177–198
    [Google Scholar]
  43. Suzuki H., Takahashi T., Kuroihi T., Suyama M., Ariyoshi Y., Takahashi T., Ueda R. 1992; p53 mutations in non-small cell lung cancer in Japa: association between mutations and smoking. Cancer Research 52:734–736
    [Google Scholar]
  44. Syrjanen S., von Krogh G., Kellokoski J., Syrjänen K. 1989; Two different human papillomavirus (HPV) types associated with oral mucosal lesions in an HIV-seropositive man. Journal of Oral Pathology and Medicine 18:366–370
    [Google Scholar]
  45. Top B. 1992; A simple method to attach a universal 50-bp GC-clamp to PCR fragments used for mutation analysis by DGGE. PCR Methods and Applications 1:83–85
    [Google Scholar]
  46. van den Brule A. J. C., Meijer C. J. L. M., Bakels V., Kenemans P., Walboomers J. M. M. 1990; Rapid detection of human papillomavirus in cervical scrapes by combined general primer- mediated and type-specific polymerase chain reaction. Journal of Clinical Microbiology 28:2739–2743
    [Google Scholar]
  47. Werness B. A., Levine A. J., Howley P. M. 1990; Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76–79
    [Google Scholar]
  48. Wynford-Thomas D. 1992; p53 in tumour pathology: can we trust immunocytochemistry?. Journal of Pathology 166:329–330
    [Google Scholar]
  49. zur Hausen H. 1991; Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9–13
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-10-2769
Loading
/content/journal/jgv/10.1099/0022-1317-75-10-2769
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error